Indian coleus: A comprehensive examination of its properties and the adverse effects associated with forskolin
Isabella Taylor
2026-05-19
3 min. read
Indian coleus: A comprehensive examination of its properties and the adverse effects associated with forskolin
46
views
While common nettle is widely recognized and appreciated in our region for its health-promoting attributes, its Indian counterpart—scientifically termed *Coleus forskohlii*—remains an underappreciated yet highly valuable botanical resource with substantial therapeutic potential. Beyond its well-documented medicinal benefits, this plant plays a pivotal role as an adjunctive agent in the management of obesity and metabolic disorders. The following article provides an in-depth exploration of its prospective applications, coupled with a rigorous assessment of potential adverse reactions, to facilitate informed and safe integration into health-related practices.
Indian scallops (forskolin)
The most desirable part of the plant is its root, as it is responsible for its beneficial effects. It naturally comes from India, but it is also very well known in African countries. It is used there, as in Indian and Ayurvedic medicine, because of its remarkable medicinal properties. The most sought-after part is its roots, because they are responsible for the beneficial effect. It also contains forskolin, which it produces.
Adverse reactions of forskolin
However, due to the lack of adequate samples taken on children and pregnant or breastfed women, most sources report that the plant and its extracts are completely safe. No side effects or adverse reactions have been observed in the experimental studies at the recommended doses. No hepatotoxic effects have been found. However, the majority of the studies do not consider the health and safety of this plant and the extracts made from it. Therefore, it is not recommended to use any side effects of the drug in patients who are suffering from a blood clot, or that it may result in an interaction with blood clots (especially in patients with diabetes).